ATRYS Financial Statements From 2010 to 2025
| A2T Stock | EUR 2.77 0.16 5.46% |
Check ATRYS HEALTH financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ATRYS HEALTH's main balance sheet or income statement drivers, such as , as well as many indicators such as . ATRYS financial statements analysis is a perfect complement when working with ATRYS HEALTH Valuation or Volatility modules.
ATRYS |
ATRYS HEALTH SA Company Total Debt Analysis
ATRYS HEALTH's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current ATRYS HEALTH Total Debt | 71.4 M |
Most of ATRYS HEALTH's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ATRYS HEALTH SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, ATRYS HEALTH SA has a Total Debt of 71.4 M. This is 97.4% lower than that of the Healthcare sector and 78.02% lower than that of the Biotechnology industry. The total debt for all Germany stocks is 98.66% higher than that of the company.
ATRYS HEALTH SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ATRYS HEALTH's current stock value. Our valuation model uses many indicators to compare ATRYS HEALTH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ATRYS HEALTH competition to find correlations between indicators driving ATRYS HEALTH's intrinsic value. More Info.ATRYS HEALTH SA is number one stock in ebitda category among its peers. It also is number one stock in net income category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ATRYS HEALTH's earnings, one of the primary drivers of an investment's value.About ATRYS HEALTH Financial Statements
ATRYS HEALTH stakeholders use historical fundamental indicators, such as ATRYS HEALTH's revenue or net income, to determine how well the company is positioned to perform in the future. Although ATRYS HEALTH investors may analyze each financial statement separately, they are all interrelated. For example, changes in ATRYS HEALTH's assets and liabilities are reflected in the revenues and expenses on ATRYS HEALTH's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ATRYS HEALTH SA. Please read more on our technical analysis and fundamental analysis pages.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in ATRYS Stock
ATRYS HEALTH financial ratios help investors to determine whether ATRYS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ATRYS with respect to the benefits of owning ATRYS HEALTH security.